000			01512 a2200361 4500
005			20250513073248.0
264		0	_c19930902
008			199309s 0 0 eng d
022			_a0952-3278
024	7		_a10.1016/0952-3278(93)90047-z _2doi
040			_aNLM _beng _cNLM
100	1		_aPhillips, T E
245	0	0	_aThe effect of 16,16-dimethyl prostaglandin E2 on proliferation of an intestinal goblet cell line and its synthesis and secretion of mucin glycoproteins. _h[electronic resource]
260			_bProstaglandins, leukotrienes, and essential fatty acids _cJun 1993
300			_a423-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_a16,16-Dimethylprostaglandin E2 _xpharmacology
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aCell Division _xdrug effects
650	0	4	_aColonic Neoplasms _xdrug therapy
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aGlucosamine _xmetabolism
650	0	4	_aGlycoproteins _xdrug effects
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMucins _xdrug effects
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aStanley, C M
700	1		_aWilson, J
773	0		_tProstaglandins, leukotrienes, and essential fatty acids _gvol. 48 _gno. 6 _gp. 423-8
856	4	0	_uhttps://doi.org/10.1016/0952-3278(93)90047-z _zAvailable from publisher's website
999			_c8340996 _d8340996